Citadel Advisors’s iKang Healthcare Group, Inc. KANG Stock Holding History

Citadel Advisors’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,944	Closed	-$221K	–	9569
2018 Q1	$218K	Buy	+10,944	New	+$184K	﹤0.01%	7221
2017 Q4	–	Sell	-23,854	Closed	-$345K	–	8720
2017 Q3	$322K	Sell	23,854 -10,257	-30%	-$137K	﹤0.01%	5964
2017 Q2	$419K	Sell	34,111 -33,177	-49%	-$481K	﹤0.01%	5373
2017 Q1	$982K	Sell	67,288 -100,015	-60%	-$1.64M	﹤0.01%	4025
2016 Q4	$2.9M	Buy	167,303 +148,815	+805%	+$2.52M	﹤0.01%	2529
2016 Q3	$334K	Buy	+18,488	New	+$340K	﹤0.01%	5499
2016 Q2	–	Sell	-26,308	Closed	-$530K	–	7737
2016 Q1	$575K	Buy	26,308 +6,963	+36%	+$145K	﹤0.01%	4213
2015 Q4	$395K	Buy	+19,345	New	+$334K	﹤0.01%	4802
2015 Q2	–	Sell	-59,979	Closed	-$973K	–	9297
2015 Q1	$973K	Buy	59,979 +19,143	+47%	+$319K	﹤0.01%	3962
2014 Q4	$614K	Buy	40,836 +23,999	+143%	+$427K	﹤0.01%	4424
2014 Q3	$328K	Buy	+16,837	New	+$329K	﹤0.01%	5155

Other funds holding KANG

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Citadel Advisors's KANG Position: Q2 2018 in Review

Citadel Advisors sold out of iKang Healthcare Group, Inc. (KANG) in Q2 2018, closing a stake of 10,944 shares — an estimated $221K sold.

Citadel Advisors first reported a position in KANG in Q3 2014 and held it in 11 quarters. The position peaked at $2.9M in Q4 2016. 63 funds tracked by Wall St. Rank hold KANG as of Q2 2018.

Citadel Advisors reported no remaining iKang Healthcare Group, Inc. position as of Q2 2018 after selling out during the quarter.
Citadel Advisors sold 10,944 iKang Healthcare Group, Inc. shares in Q2 2018, an estimated $221K.
Citadel Advisors first reported a position in iKang Healthcare Group, Inc. in Q3 2014 and held it in 11 quarters.
Citadel Advisors's iKang Healthcare Group, Inc. position peaked at $2.9M in Q4 2016.
63 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q2 2018.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.